ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant.

Genovefa A Papanicolaou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.